Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
Enregistré dans:
| Auteur principal: | Theresa Bender Pape |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1af478213ae049bc97cf111b2315066f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
par: Amy Herrold, et autres
Publié: (2021) -
High Frequency rTMS Dosing for Smoking Cessation: Preliminary Findings
par: Christine Sheffer, et autres
Publié: (2021) -
rTMS Dosing for Smoking Cessation: Pre-COVID Preliminary Results
par: Chrisitine Sheffer, et autres
Publié: (2021) -
Combined rTMS/fMRI over the Motor and Prefrontal Brain Areas for Testing Therapeutic rTMS Protocols
par: Kai-Yen Chang, et autres
Publié: (2021) -
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
par: Chen SJ, et autres
Publié: (2013)